Webcast, Event, or Conference

»Webcast, Event, or Conference
4 12, 2018

Eiger BioPharmaceuticals to Host R&D Day in New York City

2018-12-04T14:51:54+00:00

Eiger BioPharmaceuticals to Host R&D Day in New York City PALO ALTO, Calif., December 4, 2018 – Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for rare and ultra-rare diseases, today announced it will host an R&D Day on December 11, 2018 from 12:00 PM to 2:30 PM EST at [...]

Eiger BioPharmaceuticals to Host R&D Day in New York City2018-12-04T14:51:54+00:00
19 11, 2018

Eiger to Participate in Piper Jaffray Healthcare Conference

2018-11-21T11:28:38+00:00

Eiger to Participate in Piper Jaffray Healthcare Conference PALO ALTO, Calif., November 19, 2018 – Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for rare diseases, today announced that David Cory, President and CEO, will present a corporate update at the 30th Annual Piper Jaffray Healthcare Conference on November 27 [...]

Eiger to Participate in Piper Jaffray Healthcare Conference2018-11-21T11:28:38+00:00
18 10, 2018

Eiger BioPharmaceuticals to Participate at BTIG Biotech Conference

2018-10-18T17:03:58+00:00

Eiger BioPharmaceuticals to Participate at BTIG Biotech Conference PALO ALTO, Calif., October 18, 2018 – Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for rare diseases, today announced the Eiger management team will participate and host 1:1 investor meetings at the BTIG Biotech Conference at the Langham Hotel in New [...]

Eiger BioPharmaceuticals to Participate at BTIG Biotech Conference2018-10-18T17:03:58+00:00
25 09, 2018

Eiger BioPharmaceuticals to Participate in Investor Conferences

2018-09-25T13:50:24+00:00

Eiger BioPharmaceuticals to Participate in Investor Conferences PALO ALTO, Calif., September 25, 2018 – Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for rare and ultra-rare diseases, today announced that David Cory, President and CEO, will present at two investor conferences in October in New York City. Cantor Fitzgerald 4th [...]

Eiger BioPharmaceuticals to Participate in Investor Conferences2018-09-25T13:50:24+00:00
27 08, 2018

Eiger BioPharmaceuticals to Participate in Investor Conferences

2018-08-29T18:26:56+00:00

Eiger BioPharmaceuticals to Participate in Investor Conferences PALO ALTO, Calif., August 27, 2018 – Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced today that members of the Eiger management team will participate in multiple investor conferences in September in New York City. Details of [...]

Eiger BioPharmaceuticals to Participate in Investor Conferences2018-08-29T18:26:56+00:00
4 06, 2018

Eiger Announces HDV Phase 2 Program Oral Presentation and Investigator / Key Opinion Leader Reception for Planned HDV Phase 3 D-LIVR Study at Global Hepatitis Summit 2018™

2018-06-04T15:46:20+00:00

Eiger Announces HDV Phase 2 Program Oral Presentation and Investigator / Key Opinion Leader Reception for Planned HDV Phase 3 D-LIVR Study at Global Hepatitis Summit 2018™ PALO ALTO, Calif., June 4, 2018 -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced today that an oral presentation [...]

Eiger Announces HDV Phase 2 Program Oral Presentation and Investigator / Key Opinion Leader Reception for Planned HDV Phase 3 D-LIVR Study at Global Hepatitis Summit 2018™2018-06-04T15:46:20+00:00
30 05, 2018

Eiger BioPharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference

2018-05-30T22:08:39+00:00

Eiger BioPharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference PALO ALTO, Calif. – May 30, 2018 – Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on bringing to market novel product candidates for the treatment of rare diseases, announced today that David Cory, President and CEO, will present a corporate update at Jefferies 2018 Global Healthcare Conference [...]

Eiger BioPharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference2018-05-30T22:08:39+00:00
2 04, 2018

Eiger BioPharmaceuticals to Participate in Conferences in April

2018-04-02T12:18:56+00:00

Eiger BioPharmaceuticals to Participate in Conferences in April PALO ALTO, Calif. – April 2, 2018 – Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced today that Eiger will participate at upcoming investor, scientific, and orphan drug conferences in April. C. Wainwright Global Life Science Conference at [...]

Eiger BioPharmaceuticals to Participate in Conferences in April2018-04-02T12:18:56+00:00
6 03, 2018

Eiger BioPharmaceuticals to Participate in U.S. and International Investor and Partnership Conferences in March

2018-03-06T15:15:03+00:00

Eiger BioPharmaceuticals to Participate in U.S. and International Investor and Partnership Conferences in March PALO ALTO, Calif. – March 6, 2018 – Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced today that David Cory, President and CEO of Eiger, will present a corporate overview and business [...]

Eiger BioPharmaceuticals to Participate in U.S. and International Investor and Partnership Conferences in March2018-03-06T15:15:03+00:00
5 03, 2018

Eiger Announces Abstracts and Presentations of LOWR HDV Program and Planned Registration Program at The International Liver Congress™ Meeting

2018-03-05T16:00:23+00:00

Eiger Announces Abstracts and Presentations of LOWR HDV Program and Planned Registration Program at The International Liver Congress™ Meeting PALO ALTO, Calif., March 5, 2018 -- Eiger BioPharmaceuticals, Inc., (NASDAQ: EIGR) today announced that abstracts from its LOWR HDV (LOnafarnib With Ritonavir in Hepatitis Delta Virus) Program will be presented at The International Liver Congress™ [...]

Eiger Announces Abstracts and Presentations of LOWR HDV Program and Planned Registration Program at The International Liver Congress™ Meeting2018-03-05T16:00:23+00:00